Farmacia
Facultad
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (100)
2024
-
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer
Clinical Cancer Research, Vol. 30, Núm. 5, pp. 975-983
-
The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era
Current Opinion in Obstetrics and Gynecology, Vol. 36, Núm. 2, pp. 104-111
2023
-
Advances in immunotherapy for cervical cancer
Therapeutic Advances in Medical Oncology, Vol. 15
-
Advances in immunotherapy in cervical cancer
International Journal of Gynecological Cancer, Vol. 33, Núm. 3, pp. 403-413
-
COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
BMC Health Services Research, Vol. 23, Núm. 1
-
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia
Farmacia Hospitalaria, Vol. 47, Núm. 3, pp. 100-105
-
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)
Leukemia
-
Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)
Frontiers in Microbiology
-
Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1
Journal of medical economics, Vol. 26, Núm. 1, pp. 445-453
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
-
Drug-related problems as reason for emergency department visit: 3 years of the FARM-URG registry
International Journal of Pharmacy Practice, Vol. 31, Núm. 4, pp. 417-422
-
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain
BMC Pulmonary Medicine, Vol. 23, Núm. 1
-
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370
-
Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review
Journal of Clinical Medicine, Vol. 12, Núm. 21
-
The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)
Frontiers in Microbiology, Vol. 14
2022
-
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation
International Journal of Gynecological Cancer, Vol. 32, Núm. 9, pp. 1196-1200
-
Applying reflective multicriteria decision analysis to understand the value of therapeutic alternatives in the management of gestational and peripartum anaemia in Spain
BMC Pregnancy and Childbirth, Vol. 22, Núm. 1
-
CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3
Frontiers in Microbiology, Vol. 13
-
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults
Antibiotics, Vol. 11, Núm. 9
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1